- Home
- ZLAB vs DCO Comparison
ZLAB vs DCO Comparison
Compare ZLAB & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | DCO |
|---|---|---|
| Founded | 2013 | 1849 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | DCO |
|---|---|---|
| Price | $17.53 | $121.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $49.60 | ★ $150.20 |
| AVG Volume (30 Days) | ★ 680.7K | 143.3K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $460,156,000.00 | ★ $824,730,000.00 |
| Revenue This Year | $14.46 | $7.38 |
| Revenue Next Year | $29.47 | $8.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | 4.85 |
| 52 Week Low | $15.96 | $51.76 |
| 52 Week High | $44.34 | $140.02 |
Technical Indicators
Market Signals| Indicator | ZLAB | DCO |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 45.72 |
| Support Level | $17.03 | $87.68 |
| Resistance Level | $19.49 | $128.17 |
| Average True Range (ATR) | 0.60 | 4.29 |
| MACD | -0.16 | -1.04 |
| Stochastic Oscillator | 11.49 | 13.63 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About DCO Ducommun Incorporated
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.